News & Events

As EU Microbiome Regulatory Science Center, the PRI aims to communicate on the most relevant news and updates surrounding the regulatory and scientific landscape for the development of microbiome-based medicinal products.

As a not-for-profit, financially independent Association, we welcome those interested in the field to share (contact us) any relevant information to be diffused in this section of our website.

Delphi Survey on Microbiome Biomarkers closes 10 April!

Delphi Survey on Microbiome Biomarkers closes 10 April!

UPDATE (07/04/23) The Delphi Survey on finding a consensus around the development and validation of microbiome-based biomarkers is almost closed! The Survey platform will be open to accept submissions until 10 April. Once the platform closes, the...

read more
2022 PRI Member Event – Rotterdam, NL

2022 PRI Member Event – Rotterdam, NL

All PRI Members are invited to attend our first in-person Member Event since 2019! The Pharmabiotic Research Institute (PRI) is hosting its annual General Assembly & Member Event on 1 December 2022, in Rotterdam (NL). This Members-only meeting...

read more
EU-Innovation Network (EMA) Horizon Scanning Report FMT

EU-Innovation Network (EMA) Horizon Scanning Report FMT

On 13 June 2022 the EU-Innovation Network (jointly coordinated by the European Medicines Agency - EMA, and the Heads of Medicines Agencies - HMA) published a Horizon Scanning Report on Faecal Microbiota Transplantation. The report describes the use...

read more
Pharmabiotics 2022 Conference & Partnering

Pharmabiotics 2022 Conference & Partnering

The Pharmabiotics 2022 Conference & Partnering Event was held on 20-21 April 2022 in Lyon, France. Nearly 200 delegates from industry and academia joined together to discuss a range of topics focusing on microbiome regulatory science,...

read more